Greetings, and thanks to Megan for giving me a chance to double-blog with all of you. As many of you already know, my day job -- outside of all this lucrative blogging stuff - is in drug discovery. So while I'll confine my opinions on pharmacokinetic assays and fluorination reactions to my own site, my thoughts over here will often have connections to science, technology, and medicine.
To read the full, original article click on this link: What Is Behind Pharma's Innovation Drought? - Megan McArdle - Business - The Atlantic
